These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8889578)

  • 1. Glucocerebrosidase (Gaucher disease).
    Beutler E; Gelbart T
    Hum Mutat; 1996; 8(3):207-13. PubMed ID: 8889578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; Gaucher disease].
    Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
    Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.
    Lau EK; Tayebi N; Ingraham LJ; Winfield SL; Koprivica V; Stone DL; Zimran A; Ginns EI; Sidransky E
    Hum Genet; 1999 Apr; 104(4):293-300. PubMed ID: 10369158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurogenetics in Gaucher disease.
    Brady RO; Barton NW; Grabowski GA
    Arch Neurol; 1993 Nov; 50(11):1212-24. PubMed ID: 8215980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gaucher disease: importance of early diagnosis and therapy].
    Simon G; Erdos M; Maródi L; Tóth J
    Orv Hetil; 2008 Apr; 149(16):743-50. PubMed ID: 18426721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation.
    Sheth J; Bhavsar R; Mistri M; Pancholi D; Bavdekar A; Dalal A; Ranganath P; Girisha KM; Shukla A; Phadke S; Puri R; Panigrahi I; Kaur A; Muranjan M; Goyal M; Ramadevi R; Shah R; Nampoothiri S; Danda S; Datar C; Kapoor S; Bhatwadekar S; Sheth F
    BMC Med Genet; 2019 Feb; 20(1):31. PubMed ID: 30764785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
    Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
    Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct haplotype in non-Ashkenazi Gaucher patients with N370S mutation.
    Amaral O; Marcão A; Pinto E; Zimran A; Miranda MC
    Blood Cells Mol Dis; 1997 Dec; 23(3):415-6. PubMed ID: 9446756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher disease: a lysosomal neurodegenerative disorder.
    Huang WJ; Zhang X; Chen WW
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1219-26. PubMed ID: 25912581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease: new molecular approaches to diagnosis and treatment.
    Beutler E
    Science; 1992 May; 256(5058):794-9. PubMed ID: 1589760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease.
    Zimran A; Horowitz M
    Am J Med Genet; 1994 Mar; 50(1):74-8. PubMed ID: 8160756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the origin of the Gaucher disease-causing mutation N370S: extended haplotype analysis using the 5GC3.2, 5470 G/A, and ITG6.2 polymorphisms.
    Rodríguez-Marí A; Díaz-Font A; Chabás A; Pastores GM; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2001; 27(5):950-9. PubMed ID: 11783960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1448C mutation linked to the Pv1.1- genotype in Italian patients with Gaucher disease.
    Tuteja R; Bembi B; Agosti E; Baralle FE
    Hum Mol Genet; 1993 Jun; 2(6):781-4. PubMed ID: 8102572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insertion mutation in a non-Jewish Caucasian type 1 Gaucher disease patient.
    Choy FY; Humphries ML; Ferreira P
    Am J Med Genet; 1997 Jan; 68(2):211-5. PubMed ID: 9028460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: the N370S mutation in Ashkenazi Jewish and Spanish patients has a common origin and arose several thousand years ago.
    Díaz A; Montfort M; Cormand B; Zeng B; Pastores GM; Chabás A; Vilageliu L; Grinberg D
    Am J Hum Genet; 1999 Apr; 64(4):1233-8. PubMed ID: 10090913
    [No Abstract]   [Full Text] [Related]  

  • 18. The N370S mutation in the glucocerebrosidase gene of Portuguese type 1 Gaucher patients: linkage to the PvuII polymorphism.
    Lacerda L; Amaral O; Pinto R; Aerts J; Sá Miranda MC
    J Inherit Metab Dis; 1994; 17(1):85-8. PubMed ID: 8051940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I Gaucher disease due to homozygosity for the 259T mutation in a Bedouin patient.
    Rockah R; Narinsky R; Hatskelzon L; Frisch A
    Am J Med Genet; 1997 Oct; 72(1):77-8. PubMed ID: 9295080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enzyme replacement therapy for Gaucher disease introduced in late adulthood].
    Juhász P; Tóth B; Maródi L; Erdos M
    Orv Hetil; 2012 Feb; 153(7):264-70. PubMed ID: 22318527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.